{"id":"W4379284089","doi":"10.1200/jco.2023.41.16_suppl.tps616","title":"lidERA Breast Cancer (BC): Phase III adjuvant study of giredestrant vs. physician’s choice of endocrine therapy (PCET) in patients (pts) with estrogen receptor-positive, HER2-negative early BC (ER+, HER2– eBC).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Letrozole; Tamoxifen; Internal medicine; Anastrozole; Oncology; Exemestane; Fulvestrant; Breast cancer; Tolerability; Estrogen receptor; Hazard ratio; Adverse effect; Cancer; Gynecology; Confidence interval","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000956076,0.0003790928,0.003052023,0.0003126391,0.00004939062,0.000007468903,0.0003275004,0.0001992797,0.000156162],"category_scores_gemma":[0.000340758,0.0002658832,0.0003842177,0.0007541048,0.0004969056,0.0003094249,0.00006762891,0.001175624,0.000006178722],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003826539,"about_ca_system_score_gemma":0.001296968,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003436039,"about_ca_topic_score_gemma":0.0007159912,"domain_scores_codex":[0.9943778,0.00071938,0.003065218,0.0004367348,0.0008997779,0.0005010751],"domain_scores_gemma":[0.9928982,0.001677115,0.003361691,0.000345996,0.001383247,0.0003337226],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08870395,0.0194872,0.5203077,0.00005147235,0.001907162,0.0003513313,0.002468979,0.0002543294,0.0008301105,0.000007221618,0.0001676628,0.365463],"study_design_scores_gemma":[0.09735624,0.06286316,0.8344183,0.0006800945,0.0002819032,0.00003761955,0.001397309,0.00002152947,0.001795877,0.00005573601,0.0008926312,0.0001996119],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995765,0.000195717,0.0000167022,0.002200913,0.0005079483,0.001094964,0.00009175028,0.00002107357,0.0001059233],"genre_scores_gemma":[0.9972687,0.0007319758,0.0005293083,0.0005765178,0.0006804559,0.00004930615,0.000008693757,0.00006547293,0.00008959278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3652633,"threshold_uncertainty_score":0.9999793,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05948224414837465,"score_gpt":0.4391421162090012,"score_spread":0.3796598720606266,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}